Oncogene

Links to selected research papers and review-type articles from Oncogene in the field of cancer can be accessed below.

• Reviews

  • The p53 pathway: positive and negative feedback loops

    Sandra L Harris and Arnold J Levine

    Journal:Oncogene 24, 2899-2908 (2005); doi:10.1038/sj.onc.1208615

    • Abstract |
    • Full text |
    • PDF (160K)

  • Cyclins and cdks in development and cancer: a perspective

    Amit Deshpande, Peter Sicinski and Philip W Hinds

    Journal:Oncogene 24, 2909-2915 (2005); doi:10.1038/sj.onc.1208618

    • Abstract |
    • Full text |
    • PDF (152K)

  • Multisite protein modification and intramolecular signaling

    Xiang-Jiao Yang

    Journal:Oncogene 24, 1653-1662 (2004); doi:10.1038/sj.onc.1208173

    • Abstract |
    • Full text |
    • PDF (284K)

  • Self-renewal of teratocarcinoma and embryonic stem cells

    Ian Chambers and Austin Smith

    Journal:Oncogene 23, 7150-7160 (2004); doi:10.1038/sj.onc.1207930

    • Abstract |
    • Full text |
    • PDF

  • Cancer stem cells in nervous system tumors

    Sheila K Singh, Ian D Clarke, Takuichiro Hide and Peter B Dirks

    Journal:Oncogene 23, 7267-7273 (2004); doi:10.1038/sj.onc.1207946

    • Abstract |
    • Full text |
    • PDF

  • Original Papers

    • Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM

      Hiroyuki Tagawa, Sivasundaram Karnan, Ritsuro Suzuki, Keitaro Matsuo, Xiaohua Zhang, Akinobu Ota, Yasuo Morishima, Shigeo Nakamura and Masao Seto

      Journal:Oncogene 24, 1348-1358 (2004); doi:10.1038/sj.onc.1208300

      • Abstract |
      • Full text |
      • PDF (532K)

    • Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

      Susumu Nakata, Tatsushi Yoshida, Mano Horinaka, Takumi Shiraishi, Miki Wakada and Toshiyuki Sakai

      Journal:Oncogene 23, 6261-6271 (2004); doi:10.1038/sj.onc.1207830

      • Abstract |
      • Full text |
      • PDF

    • Short Reports

      • Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer

        Milo Frattini, Cristina Ferrario, Paola Bressan, Debora Balestra, Loris De Cecco, Piera Mondellini, Italia Bongarzone, Paola Collini, Manuela Gariboldi, Silvana Pilotti, Marco A Pierotti and Angela Greco

        Journal:Oncogene 23, 7436-7440 (2004); doi:10.1038/sj.onc.1207980

        • Abstract |
        • Full text |
        • PDF

      • B-RAF is a therapeutic target in melanoma

        Maria Karasarides, Antonio Chiloeches, Robert Hayward, Dan Niculescu-Duvaz, Ian Scanlon, Frank Friedlos, Lesley Ogilvie, Douglas Hedley, Jan Martin, Christopher J Marshall, Caroline J Springer and Richard Marais

        Journal:Oncogene 23, 6292-6298 (2004); doi:10.1038/sj.onc.1207785

        • Abstract |
        • Full text |
        • PDF

• Oncogenomics

  • PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas

    Jong Woo Lee, Young Hwa Soung, Su Young Kim, Hae Woo Lee, Won Sang Park, Suk Woo Nam, Sang Ho Kim, Jung Young Lee, Nam Jin Yoo and Sug Hyung Lee

    Journal:Oncogene 24, 1477-1480 (2004); doi:10.1038/sj.onc.1208304

    • Abstract |
    • Full text |
    • PDF (132K)